• LAST PRICE
    9.0300
  • TODAY'S CHANGE (%)
    Trending Up0.0500 (0.5568%)
  • Bid / Lots
    8.9100/ 2
  • Ask / Lots
    9.8600/ 1
  • Open / Previous Close
    8.9200 / 8.9800
  • Day Range
    Low 8.7500
    High 9.0300
  • 52 Week Range
    Low 5.1500
    High 12.4500
  • Volume
    500,351
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 8.95
TimeVolumeCNTA
09:32 ET12808.92
09:36 ET3008.905
09:39 ET252008.955
09:41 ET1118.93
09:48 ET1008.96
09:50 ET1008.95
09:54 ET1048.9111
09:59 ET1008.95
10:12 ET1008.935
10:14 ET19008.93
10:15 ET2008.93
10:19 ET2008.93
10:21 ET3008.965
10:24 ET3008.96
10:26 ET6008.92
10:28 ET8008.93
10:30 ET11668.96
10:32 ET12208.92
10:33 ET3008.94
10:35 ET8508.94
10:37 ET4008.94
10:39 ET4008.93
10:42 ET5008.95
10:44 ET21378.93
10:46 ET9008.96
10:48 ET2008.97
10:50 ET4008.96
10:51 ET2008.92
10:53 ET1008.96
10:55 ET1008.96
10:57 ET3008.96
11:00 ET3008.96
11:02 ET262468.945
11:04 ET2008.935
11:06 ET4008.95
11:08 ET1008.935
11:11 ET12618.94
11:13 ET13618.94
11:15 ET6588.95
11:18 ET40878.92
11:20 ET2008.91
11:22 ET1008.92
11:24 ET1008.91
11:26 ET14878.9
11:27 ET23508.93
11:29 ET4468.93
11:31 ET2008.91
11:33 ET451888.88
11:36 ET44058.88
11:38 ET2008.85
11:40 ET2008.88
11:42 ET57508.85
11:44 ET22388.85
11:45 ET4008.86
11:47 ET6468.855
11:49 ET2008.85
11:51 ET1008.85
11:54 ET3418.85
11:56 ET2008.85
11:58 ET1008.845
12:00 ET2198.85
12:02 ET6258.85
12:03 ET3008.85
12:05 ET5278.89
12:09 ET4118.85
12:12 ET1098.85
12:14 ET39048.805
12:16 ET2008.805
12:18 ET6138.79
12:20 ET16598.81
12:21 ET12268.79
12:23 ET4968.8
12:27 ET1008.795
12:30 ET1008.82
12:32 ET2008.805
12:36 ET4008.805
12:39 ET1008.805
12:45 ET3008.77
12:52 ET1008.8
12:54 ET1008.8
12:56 ET1008.8
01:03 ET1008.8
01:06 ET4008.82
01:08 ET2098.8
01:12 ET1008.8
01:14 ET11728.83
01:15 ET1008.825
01:17 ET4098.83
01:21 ET5278.8
01:24 ET5098.77
01:28 ET5468.77
01:32 ET15298.75
01:33 ET14008.77
01:35 ET3008.76
01:37 ET3738.775
01:39 ET5618.775
01:42 ET1008.775
01:44 ET2008.76
01:48 ET2008.775
01:50 ET10608.795
01:51 ET1008.8
01:53 ET1008.83
01:57 ET1008.805
02:00 ET6008.795
02:02 ET5008.78
02:04 ET3088.8
02:09 ET4008.815
02:11 ET1008.81
02:13 ET1008.815
02:15 ET2148.82
02:20 ET7008.83
02:24 ET19728.82
02:27 ET12008.85
02:29 ET2008.845
02:33 ET7008.855
02:36 ET1008.88
02:38 ET6788.865
02:40 ET5348.88
02:42 ET2178.86
02:44 ET1008.86
02:45 ET5288.84
02:47 ET2008.86
02:49 ET5428.86
02:51 ET10588.84
02:54 ET3088.86
02:56 ET2008.88
02:58 ET2128.88
03:00 ET15118.89
03:02 ET19208.89
03:03 ET2008.905
03:05 ET2038.905
03:07 ET4008.905
03:09 ET3168.88
03:12 ET2008.905
03:14 ET2008.905
03:16 ET3538.88
03:18 ET3008.905
03:20 ET2008.905
03:21 ET1208.905
03:25 ET7878.9
03:27 ET3048.87
03:30 ET8338.86
03:32 ET4018.87
03:34 ET4028.89
03:36 ET6368.9
03:38 ET4008.895
03:39 ET8508.95
03:41 ET525038.91
03:43 ET14008.91
03:45 ET7428.91
03:48 ET9008.895
03:50 ET5198.87
03:52 ET34908.985
03:54 ET21768.975
03:56 ET23008.995
03:57 ET20009
03:59 ET384319.03
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCNTA
Centessa Pharmaceuticals PLC
1.0B
-6.4x
---
United StatesELVN
Enliven Therapeutics Inc
996.2M
-12.1x
---
United StatesPHVS
Pharvaris NV
984.8M
-7.4x
---
United StatesCGEM
Cullinan Therapeutics Inc
951.0M
-5.5x
---
United StatesBCYC
Bicycle Therapeutics PLC
1.0B
-4.5x
---
United StatesAUTL
Autolus Therapeutics PLC
893.9M
-2.9x
---
As of 2024-06-29

Company Information

Centessa Pharmaceuticals plc is a United Kingdom-based clinical-stage pharmaceutical company. Its advanced programs include a hemophilia program, an orexin agonist program for the treatment of narcolepsy and other sleep-wake disorders, and an immuno-oncology program focused on its LockBody technology platform. SerpinPC, its advanced product candidate, is an investigational, potentially first-in-class subcutaneously administered novel inhibitor of activated protein C for hemophilia. Its Orexin Receptor 2 (OX2R) Agonist Program includes ORX750, which is an investigational, orally administered, selective OX2R agonist designed to directly target the underlying pathophysiology of orexin neuron loss in narcolepsy type 1 and to address sleep-wake disorders with normal orexin levels such as narcolepsy type 2 and idiopathic hypersomnia. It is also exploring follow-up orexin agonists for potential expansion opportunities into a range of sleep-wake disorders and broader neurological indications.

Contact Information

Headquarters
3Rd Floor, 1 Ashley RoadALTRINCHAM, United Kingdom WA14 2DT
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Francesco de Rubertis
Chief Executive Officer, Director
Saurabh Saha
Chief Financial Officer
John Crowley
Chief People Officer
Karen Anderson
Executive Vice President and Chairman of Development
Antoine Yver

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.0B
Revenue (TTM)
$6.9M
Shares Outstanding
113.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.42
Book Value
$2.39
P/E Ratio
-6.4x
Price/Sales (TTM)
148.3
Price/Cash Flow (TTM)
---
Operating Margin
-2,312.80%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.